Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 43547-421
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 43547-421). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Solco Healthcare Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
20 12.5 30.jpg.jpg
Lisinopril And Hydrochlorothiazide Tablets 20/25 mg (100 tablets)
Lisinopril and (L IO T T (T TEPAT) Tablets, USP are medicines which need to be stored at a controlled temperature ranging from 20°C to 25°C and protected from excessive heat and the reach of children. Dosage guidance needs to be followed as per the accompanying prescription. These tablets are packaged in a 25, light-resistant container with a Canressort closure. The manufacturer is Zeiangtiana Pramscentica Co, L1 with distribution handled by SokcoHeamaie US, LLC based in Somerset, NJ 08873 USA. The text also includes a reference to wnocassar42240 R only and a notation that a box is FPO to indicate the area to be left uncoated, however, it is unclear from the text what these refer to.*
Structural Formula 1 (Image 01)
Structural Formula 2 (Image 02)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.